IN8bio Inc. is a clinical-stage biotechnology company. It focuses on developing therapies for the treatment of cancers, including solid tumors using allogeneic, autologous, and genetically modified gamma-delta T cells. The company's principal candidate includes INB-200, which are in clinical stage. IN8bio Inc. is based in New York.
Address Details
Address: 350 5th Avenue Suite 5330
City: New York
State: NY
Country: USA
Zip Code: 10118
Contact Details
646-600-6438
This weeks newsletter: 🚀 Retail Access to SpaceX, BlackBerry’s Big Moves, Trends to Watch 📈